Table 4.
Surgeon Guidelines and Criteria for Return to Play.
| Mfx | AOT | OCA | ACI | |
|---|---|---|---|---|
| Return-to-play criteria score | 1.5 ± 0.7 | 1.7 ± 0.9 | 2.2 ± 1.0 | 1.6 ± 0.6 |
| Return-to-play timeline | 26 studies | 20 studies | 38 studies | 32 studies |
| 3 months | — | 3 (15.0%) | 1 (2.6%) | 1 (3.1%) |
| 4 months | 8 (30.8%) | 3 (15.0%) | 5 (13.2%) | 1 (3.1%) |
| 5 months | — | — | — | — |
| 6 months | 10 (38.5%) | 14 (70.0%) | 23 (60.5%) | 6 (18.8%) |
| 8 months | — | — | 2 (5.3%) | 2 (6.3%) |
| 9 months | — | — | — | 3 (9.4%) |
| 10 months | 1 (3.9%) | — | — | 5 (15.6%) |
| 12 months | 4 (15.4%) | — | 7 (18.4%) | 5 (15.6%) |
| 14 months | — | — | — | 3 (9.4%) |
| 16 months | 2 (7.7%) | — | — | 2 (6.3%) |
| 18 months | 2 (7.7%) | — | — | 4 (12.5%) |
| Criteria | 26 studies | 23 studies | 41 studies | 32 studies |
| Timeline | 26 (100.0%) | 20 (87.0%) | 38 (92.7%) | 32 (100.0%) |
| Strength | — | 9 (39.1%) | 9 (22.0%) | — |
| Imaging | 1 (3.8%) | 2 (8.7%) | 8 (19.5%) | — |
| Pain/Symptoms | 3 (11.5%) | 4 (17.4%) | 2 (4.9%) | 2 (6.3%) |
| Range of motion | — | 1 (4.3%) | — | — |
Mfx = microfracture; AOT = osteochondral autograft; OCA = osteochondral allograft; ACI = autologous chondrocyte implantation.